Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Euromed's Olive Leaf Extract Demonstrates Antibacterial Properties in Published Novel Study

This Olive Leaf Extract from Euromed inhibits growth of Listeria monocytogenes - which introduces an exciting potential adjunct to help control foodborne pathogens.


News provided by

Euromed

Apr 15, 2020, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Creating the highest quality standardized botanical extracts
Creating the highest quality standardized botanical extracts

BRIDGEVILLE, Pa., April 15, 2020 /PRNewswire-PRWeb/ -- A study recently published in Nanoscale, 2020, a journal from the Royal Society of Chemistry, showed that the Olive Leaf Extract made by Euromed demonstrably inhibits the growth of the bacteria Listeria monocytogenes. Traditionally, Olive Leaf Extract has been used as an herbal dietary supplement due to it containing oleuropein and other polyphenolic compounds which have been known to offer health benefits for blood pressure, heart health and the immune system. Now, this unique study brings the good news that in addition to enhancing human health, olive leaf extract may also be used as an antimicrobial to control potential foodborne pathogens.

The full title is "Natural flagella-templated Au nanowires as a novel adjuvant against Listeria monocytogenes" and its authors are Yanhong Liu, Renjie Du, Yuejun Qu, Phoebe X. Qi, Xingpin Sunand Min Zhao. The link to the complete study is: https://pubmed.ncbi.nlm.nih.gov/32100780/?from_term=flagella-templated&from_pos=1.

We’re excited about these dual innovations: the high quality of Euromed’s Olive Leaf Extract as made by our Innovation Center in Barcelona, and advancement of food safety.

Post this

Secondary plant substances, such as olive leaf extract, are gaining increasing attention as potential antibacterial and food preservative agents. These naturally occurring compounds possess diverse chemical structures, along with a wide range of biological activities, and are ideally aligned with continuing consumer trends seeking foods produced with natural ingredients.

Innovative Approach: Gold nanowires
Foodborne pathogens such as Listeria monocytogenes – often found in dairy products, vegetables, and ready-to-eat foods – can survive and grow in harsh conditions such as low temperatures. As such, the elimination of these bacteria is a significant challenge for the food industry.

In this current study, Dr. Yanhong Liu and her research colleagues did something very unusual: They synthesized gold nanowires using bacteria flagella as a template. Gold nanowires are highly effective catalysts that improve the efficiencies of secondary plant metabolites as bacterial inhibitors. The researchers were excited to find that Euromed's Olive Leaf Extract inhibits the growth of Listeria monocytogenes completely. In addition, the gold nanowires demonstrated high electrocatalytic activity and showed NO mutagenic effect at the concentration used.

This can be profoundly good news: The gold nanowires fabricated in this work have the potential to be used as new antimicrobial packing materials to enhance food safety.

Plus, the potential here for olive leaf extract is enormous, as well.

There was a previously published study that showed promising results as well: Dr. Yanhong Liu and her fellow researchers investigated the antimicrobial effect of olive leaf extract against major foodborne pathogens, including Listeria monocytogenes, Escherichia coli, and Salmonella enteritidis. The results showed that at a concentration of 62.5 mg/ml, olive leaf extract almost completely inhibited the growth of these three pathogens. Furthermore, it also inhibited biofilm formation in Listeria monocytogenes and Salmonella enteritidis, and reduced cell motility in Listeria monocytogenes.

About EUROMED:
Founded in 1971 by the German pharmaceutical company MADAUS, Euromed is a leading producer of standardized herbal extracts and active pharmaceutical ingredients (APIs) of botanical origin for the international pharmaceutical, nutraceutical, food, and cosmetic industries.

A biomass of more than 5000 tons is extracted at the company's manufacturing facilities in Barcelona and in Murcia, Spain annually. The new production plant in Murcia further expands Euromed's capabilities with eco-friendly technologies, such as one that uses a sophisticated water-based extraction method, Pure-Hydro Process™.

All extracts comply with worldwide GMP (Good Manufacturing Practices) and international pharmacopoeias. Euromed has a long history of expertise in research and development, laboratory analyses, and extraction technologies. The company is committed to the highest quality standards in terms of analytical, chemical, and evidence-based therapeutic aspects. This experience is now available to the rapidly expanding global nutraceutical market, increasingly seeking scientifically evidence-based ingredients.

Euromed's US office headquarters is located in Bridgeville, Pennsylvania. For more information, visit http://www.euromedusa.com or call 877-696-3960.

SOURCE Euromed

Related Links

http://www.euromedusa.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.